Jim Kramer says “Danaher can make a comeback”
Danaher Corporation (NYSE:DHR) is one of Jim Kramer of 22 strains spoke recently. The caller asked if he thought it was time for Cramer to return to stock.
“Okay, I’ll let you say, we didn’t leave it for a charity trust because we believe this company will pass through. Why? I’ve known it for 30 years. I feel it’s always doing things in the end.
Medical professional in a white coat holding a microscope and looking at the slide under the lens.
Danaher (NYSE: DHR) develops and sells products and services for medical, scientific and industrial use. The company’s technology supports bioprocessing, diagnostics, laboratory automation, genomic research and clinical testing.
Although we acknowledge the potential of DHR as an investment, we believe certain AI stocks offer greater promotion potential and pose a risk of decline. If you’re looking for a highly undervalued AI stock that can make a significant profit from the tariff and supervision trends of the Trump era, check out our free report. Best Short-Term AI Stocks.
Read next: Best and worst dowstock for the next 12 months and 10 unstoppable stocks that can double your money.
Disclosure: None.